AorTech International PLC | Cash Flow

Fiscal year is April-March. All values GBP Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
518.40
202.50
401.00
181.90
33.20
Depreciation, Depletion & Amortization
151.80
206.20
207.20
224.10
220.40
Other Funds
233.70
78.90
19.30
-
40.80
Funds from Operations
132.90
75.20
174.60
42.20
227.90
Changes in Working Capital
107.70
135.40
255.60
195.70
148.70
Net Operating Cash Flow
25.20
210.60
81.00
153.50
376.60
Capital Expenditures
276.50
-
111.50
-
16.60
Net Investing Cash Flow
276.50
-
111.50
-
16.60
Net Change in Cash
217.30
175.20
30.50
153.50
360.00
Free Cash Flow
25.20
210.60
81.00
153.50
376.60
Exchange Rate Effect
84.40
35.40
-
-
-

About AorTech International

View Profile
Address
Springfield House
Weybridge Surrey KT13 9LZ
United Kingdom
Employees -
Website http://www.aortech.net
Updated 07/08/2019
AorTech International Plc is a holding company, which engages in the commercialization of biomedical polymer technology, components, and medical devices. It manufactures biostable and implantable polymers under the Elast-Eon and ECSil brands. The company was founded by James Gordon Wright and Edward McDaid in 1992 and is headquartered in Weybridge, the United Kingdom.